Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered-Dose Inhaler (pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Cardiovascular Parameters: Results from the GLIMMER Study

被引：0
|
作者：
Kerwin, E. M. [1 ]
Feldman, G. [2 ]
Beaudot, C. [3 ]
Georges, G. [4 ]
机构：
[1] Clin Res Inst, Medford, OR USA
[2] South Carolina Pharmaceut Res, Spartanburg, SC USA
[3] Chiesi USA Inc, Cary, NC USA
[4] Chiesi USA, Global Clin Dev, Cary, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7371
引用
收藏
页数：2
相关论文
共 45 条
  • [31] Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease Results of a 6-Month Randomized Clinical Trial
    Tashkin, Donald P.
    Rennard, Stephen I.
    Martin, Paula
    Ramachandran, Sulabha
    Martin, Ubaldo J.
    Silkoff, Philip E.
    Goldman, Mitchell
    DRUGS, 2008, 68 (14) : 1975 - 2000
  • [32] Effect Of β2-Adrenergic Receptor Gene Polymorphism Gly16Arg On Response To Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Chronic Obstructive Pulmonary Disease
    Bleecker, E. R.
    Meyers, D. A.
    Bailey, W. C.
    Sims, A. -M.
    Bujac, S. R.
    Goldman, M.
    Martin, U. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [33] Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
    Fakih, Faisal
    Spangenthal, Selwyn
    Sigal, Barry
    Darken, Patrick
    Maes, Andrea
    Siddiqui, Shahid
    Gillen, Michael
    Reisner, Colin
    Martin, Ubaldo J.
    RESPIRATORY MEDICINE, 2018, 138 : 74 - 80
  • [34] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) on Proportion of the Mean Peak Forced Expiratory Volume in 1 Second (FEV1) Over Time in Patients With Chronic Obstructive Pulmonary Disease or Persistent Asthma
    Ahmad, F.
    Zangrilli, J. G.
    Martin, U. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB87 - AB87
  • [35] Relationship Between Clinically Meaningful Changes in Dyspnea Score and Efficacy Outcomes in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMD)
    Celli, B. R.
    Tashkin, D. P.
    Rennard, S. I.
    McElhattan, J.
    Martin, U. J.
    Ramachandran, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [36] A PLACEBO-CONTROLLED COMPARISON BETWEEN THE BRONCHODILATORY EFFECTS OF IPRATROPIUM BROMIDE INHALED AS A DRY POWDER AND BY METERED DOSE INHALER IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    GIMENO, F
    VANVEENEN, R
    BERG, WC
    STEENHUIS, EJ
    ANNALS OF ALLERGY, 1988, 61 (05): : 341 - 343
  • [37] Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary DiseaseResults from a 1-Year Randomized Controlled Clinical Trial
    Stephen I. Rennard
    Donald P. Tashkin
    Jennifer McElhattan
    Mitchell Goldman
    Sulabha Ramachandran
    Ubaldo J. Martin
    Philip E. Silkoff
    Drugs, 2009, 69 : 549 - 565
  • [38] Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study
    Salvi, Sundeep
    Kumar, Anand
    Agrawal, Sumit
    Leuva, Amritlal
    Shukla, Vineet
    Deshpande, Shrikant Vishnu
    Balamurugan, Santhalingam
    Singh, Ajit
    Tikkiwal, Sharad
    Gupta, Sandeep K.
    Singh, Bhanu
    Lopez, Meena
    Sawant, Sandesh
    Vaidya, Abhijit
    Gogtay, Jaideep
    LUNG INDIA, 2022, 39 (05) : 408 - 416
  • [39] Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study
    Ramadan, Wijdan H.
    Sarkis, Aline T.
    CHRONIC RESPIRATORY DISEASE, 2017, 14 (03) : 309 - 320
  • [40] A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD
    Kerwin, Edward M.
    Spangenthal, Selwyn
    Kollar, Christine
    St Rose, Earl
    Reisner, Colin
    RESPIRATORY RESEARCH, 2018, 19
12345